Do Copper Peptides Actually Work? What Fifty Years Of Research Does And Does Not Show.

I want to answer this properly, which means the answer is longer than yes or no and includes the parts that do not help me.

Copper peptides have an unusual problem. There is a genuinely large body of research behind the molecule, and there is a genuinely small body of research behind the products. Those two things get blurred constantly, including by brands who should know better.

So let me separate them.

What is solidly established

GHK is a tripeptide that occurs naturally in human plasma. It was identified in 1973 by Loren Pickart, who has spent most of a career on it since. That origin story is real and it is not brand mythology.

The decline with age is documented. In a 2018 review in the International Journal of Molecular Sciences, Pickart and Margolina state it plainly: plasma GHK sits at about 200 ng/mL at age twenty and falls to around 80 ng/mL by sixty. That is a drop of roughly sixty percent, and it is the single figure the entire commercial category is built on.

The same paper reports something I find more striking, and it gets quoted less. Using gene expression data, GHK was found to alter the expression of 31.2% of human genes by fifty percent or more, increasing activity in about 59% of those and suppressing it in 41%. Whatever else this molecule is, it is not inert.

The paper also documents stimulation of collagen and certain glycosaminoglycans, and an increase in TIMP1, which is one of the proteins that restrains the enzymes that break the skin's supporting matrix down.

You can read it yourself. It is open access.

What is genuinely less settled

Here is where I part company with most of the category.

Almost every specific clinical figure you will see quoted about copper peptides is difficult to trace. There is a widely repeated study describing a percentage increase in dermal density measured by ultrasound. There is another describing head to head performance against retinoic acid, and another against vitamin C. These numbers appear on dozens of brand sites and vendor blogs.

When I went looking for the underlying papers, what I found was a chain of secondary sources citing each other, several press releases, and a lot of content written by people selling peptides. Some of the original work exists, but it is often in journals with weak reputations, and some of it traces back to companies with a direct commercial interest.

That does not mean the findings are false. It means they are not the kind of evidence you should build a purchase decision on, and I am not going to quote them at you as though they were.

What the research does not show

It does not show that a copper peptide cream produces a specific measurable result on your face in twelve weeks. That would require a controlled clinical trial on the finished product, and most brands in this category, including us at time of writing, have not published one.

It does not show that copper peptides outperform retinoids. The retinoid evidence base is decades deep and pharmaceutical grade. This is not that.

And it does not resolve the delivery question, which I think is the most important open problem in the field.

The delivery problem

A 2025 review in Molecules examined how skin permeation of GHK-Cu has actually been measured. The number it reports is uncomfortable: copper retention across the skin layers in the range of 0.6 to 2.8% of the applied dose.

The overwhelming majority of any copper peptide product does not get in. That is true of every product on the market at every concentration.

The same paper reports that ionic liquid carriers improved penetration, and that an ionic liquid microemulsion performed better still. It also explicitly names liposomal delivery as an unresolved research gap, which is worth remembering next time you see liposomal on a label as though it settles something.

So does it work

Here is my honest position.

The molecule is real, well characterised, and does measurable things in tissue. The age related decline is documented. The size makes topical delivery possible in a way it is not for most peptides. Those are strong foundations and they are more than most cosmetic actives have.

Whether a particular cream delivers enough of it, in a stable enough form, to produce a visible change on your face is a question about that cream, not about the molecule. And it is a question most brands answer with confident marketing rather than data.

We are running our own testing. When it is finished we will publish it with the method attached, including whatever it shows. Until then I would rather tell you the foundations are good and the product level evidence is thin than pretend otherwise.

How to read any copper peptide brand's claims

Ask whether the study they are citing was done on the molecule or on their product. Almost always it is the molecule.

Ask whether the study is linked. If it is not, there is usually a reason.

And be suspicious of very precise numbers with no source. A percentage quoted to two decimal places without a citation is a marketing figure, not a measurement.